| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9188043 | Clinical Neurology and Neurosurgery | 2005 | 7 Pages |
Abstract
This multimodal approach is well tolerated, and quality of life remains preserved. The relatively long median survival time is promising but a further randomised double blind placebo controlled parallel designed clinical trial should be performed to confirm these results.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Markus W. Gross, Riglef Altscher, Michael Brandtner, Harald Haeusser-Mischlich, Ion C. Chiricuta, Alessandra D. Siegmann, Rita Engenhart-Cabillic,